Propel Bio Management »

Silence Therapeutics shares owned by Propel Bio Management

Quarter-by-quarter ownership of Silence Therapeutics (SLN) shares owned by Propel Bio Management from 13F filings

Historical chart of Propel Bio Management investment in Silence Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Silence Therapeutics held by Propel Bio Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Silence Therapeutics by Propel Bio Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $2.1M 192k 10.98

More positions owned by Propel Bio Management

Plains Gp Holdings Lp-cl Comm (PAGP)
Achieve Life Sciences Comm (ACHV)
Corcept Therapeutics Comm (CORT)
Phathom Pharmaceuticals I Comm (PHAT)
Delcath Systems Comm (DCTH)
Milestone Pharmaceuticals Comm (MIST)
Compass Pathways Adrs (CMPS)
Kyverna Therapeutics Comm (KYTX)
Artiva Biotherapeutics In Comm (ARTV)
Abeona Therapeutics Comm (ABEO)
Aquestive Therapeutics In Comm (AQST)
Palisade Bio Comm (PALI)
Immunic Comm (IMUX)
Inventiva Sa - Comm (IVA)
Sab Biotherapeutics Comm (SABS)

View all positions for Propel Bio Management

Top funds holding Silence Therapeutics

Siren
TCG Crossover Management
Redmile Group
Nantahala Capital Management
Citadel Advisors
Polygon Management
Nextech Invest
Millennium Management
Ikarian Capital
Soleus Capital Management
Balyasny Asset Management
5AM Venture Management
Caption Management
Dr. Jeffrey R. Jay, M.D.
Jane Street

View all funds holding Silence Therapeutics